SYNGENE.NS Balance Sheet
Syngene International Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-24 00:31
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹2,383.40 Cr. | ₹2,378.30 Cr. | ₹2,322.60 Cr. | ₹2,545.40 Cr. | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹176.90 Cr. | ₹836.80 Cr. | ₹1,261.40 Cr. | ₹1,040.40 Cr. | CapitalWorkInProgress |
| Goodwill | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | Goodwill |
| Other Intangible Assets | ₹235.40 Cr. | ₹430.60 Cr. | ₹444.80 Cr. | ₹423.10 Cr. | OtherIntangibleAssets |
| Non-current Investments | ₹94.10 Cr. | ₹34.70 Cr. | ₹36.20 Cr. | ₹285.00 Cr. | NoncurrentInvestments |
| Other Non-current Assets | ₹163.00 Cr. | ₹206.00 Cr. | ₹159.20 Cr. | ₹138.80 Cr. | OtherNoncurrentAssets |
| Total Non-current Assets | ₹3,405.70 Cr. | ₹4,192.60 Cr. | ₹4,508.60 Cr. | ₹4,911.90 Cr. | NoncurrentAssets |
| Inventories | ₹332.80 Cr. | ₹238.50 Cr. | ₹155.50 Cr. | ₹141.30 Cr. | Inventories |
| Trade Receivables | ₹529.30 Cr. | ₹441.60 Cr. | ₹526.70 Cr. | ₹508.80 Cr. | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹89.50 Cr. | ₹85.70 Cr. | ₹367.10 Cr. | ₹228.60 Cr. | CashAndCashEquivalents |
| Current Investments | ₹824.40 Cr. | ₹513.20 Cr. | ₹610.50 Cr. | ₹456.10 Cr. | CurrentInvestments |
| Other Current Assets | ₹105.90 Cr. | ₹112.20 Cr. | ₹130.00 Cr. | ₹166.30 Cr. | OtherCurrentAssets |
| Total Current Assets | ₹2,425.30 Cr. | ₹1,959.00 Cr. | ₹2,287.30 Cr. | ₹2,142.80 Cr. | CurrentAssets |
| Total Assets | ₹5,831.00 Cr. | ₹6,151.60 Cr. | ₹6,795.90 Cr. | ₹7,054.70 Cr. | Assets |
| Equity Share Capital | ₹401.40 Cr. | ₹402.00 Cr. | ₹402.50 Cr. | ₹402.90 Cr. | EquityShareCapital |
| Other Equity | ₹3,216.60 Cr. | ₹3,855.70 Cr. | ₹4,324.30 Cr. | ₹4,436.20 Cr. | OtherEquity |
| Equity Attributable to Owners | ₹3,618.00 Cr. | ₹4,257.70 Cr. | ₹4,726.80 Cr. | ₹4,839.10 Cr. | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | N/A | N/A | N/A | N/A | NonControllingInterest |
| Total Equity | ₹3,618.00 Cr. | ₹4,257.70 Cr. | ₹4,726.80 Cr. | ₹4,839.10 Cr. | Equity |
| Long-term Borrowings | ₹489.00 Cr. | ₹100.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹1,024.80 Cr. | ₹749.60 Cr. | ₹672.70 Cr. | ₹663.30 Cr. | NoncurrentLiabilities |
| Short-term Borrowings | ₹86.30 Cr. | ₹41.70 Cr. | ₹119.60 Cr. | ₹9.40 Cr. | BorrowingsCurrent |
| Trade Payables | ₹258.00 Cr. | ₹255.50 Cr. | ₹352.00 Cr. | ₹347.50 Cr. | TradePayablesCurrent |
| Other Current Liabilities | ₹656.60 Cr. | ₹610.90 Cr. | ₹719.60 Cr. | ₹778.30 Cr. | OtherCurrentLiabilities |
| Total Current Liabilities | ₹1,188.20 Cr. | ₹1,144.30 Cr. | ₹1,396.40 Cr. | ₹1,552.30 Cr. | CurrentLiabilities |
| Total Equity and Liabilities | ₹5,831.00 Cr. | ₹6,151.60 Cr. | ₹6,795.90 Cr. | ₹7,054.70 Cr. | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from SYNGENE.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).